Zacks Investment Research on MSN

Ocugen's gene-agnostic eye therapies could reshape late-stage care

Ocugen OCGN is advancing a retinal pipeline built around durability and breadth. Its focus is a modifier gene therapy ...
Healio

Expert shares tips for safe subretinal delivery of gene therapy

Please provide your email address to receive an email when new articles are posted on . FORT LAUDERDALE, Fla. — Best practices for safe subretinal delivery of gene therapy were presented at the Retina ...
Healio

‘One-and-done’ gene therapy could shift wet AMD treatment paradigm

Please provide your email address to receive an email when new articles are posted on . Sura-vec injection reduced the annualized anti-VEGF injection rate by 76% with a high dose and 77% with a low ...
Business Insider

Editas Medicine Reports Data Demonstrating Subretinal Injection of EDIT-101 Well-tolerated in Non-human PrimatesPresentation at the Annual Meeting of the American Society of ...

CAMBRIDGE, Mass., May 18, 2018 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced results from a pre-clinical study demonstrating that EDIT-101 ...
EurekAlert!

Subretinal injection (IMAGE)

These images are the results of a subretinal injection. Left is the image of the injection site in the retina, the green box indicates the plane in which the right image was taken. Right is the ...